Unmet Medical Need in Treatment of Heart Failure Patients with Atrial … – Fort Mills Times
|
Unmet Medical Need in Treatment of Heart Failure Patients with Atrial …
Fort Mills Times ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation, heart failure and other cardiovascular diseases, today announced that the editorial “Treatment of the Heart Failure … |


